The potential and limitations of data from population-based state cancer registries

doi:10.2105/ajph.90.5.695

Cited by 104 publications

(22 citation statements)

References 15 publications

(12 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In situ breast cancer holds the potentials for malignant transformation. The systematic collection, analysis and reporting of data on carcinoma in situ might help identify risk factors and clarify underlying mechanisms of malignant transformation, thus contributing to breast cancer control research and more targeted treatments [17,18]. …”

Section: Discussionmentioning

confidence: 99%

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records

Piscitelli

Barba²,

Crespi³

et al. 2012

J Exp Clin Cancer Res

View full text Add to dashboard Cite

BackgroundWhere population coverage is limited, the exclusive use of Cancer Registries might limit ascertainment of incident cancer cases. We explored the potentials of Nationwide hospital discharge records (NHDRs) to capture incident breast cancer cases in Italy.MethodsWe analyzed NHDRs for mastectomies and quadrantectomies performed between 2001 and 2008. The average annual percentage change (AAPC) and related 95% Confidence Interval (CI) in the actual number of mastectomies and quadrantectomies performed during the study period were computed for the full sample and for subgroups defined by age, surgical procedure, macro-area and singular Region. Re-admissions of the same patients were separately presented.ResultsThe overall number of mastectomies decreased, with an AAPC of −2.1% (−2.3 -1.8). This result was largely driven by the values observed for women in the 45 to 64 and 65 to 74 age subgroups (−3.0%, -3.4 -3.6 and −3.3%, -3.8 -2.8, respectively). We observed no significant reduction in mastectomies for women in the remaining age groups. Quadrantectomies showed an overall +4.7 AAPC (95%CI:4.5–4.9), with no substantial differences by age. Analyses by geographical area showed a remarkable decrease in mastectomies, with inter-regional discrepancies possibly depending upon variability in mammography screening coverage and adherence. Quadrantectomies significantly increased, with Southern Regions presenting the highest average rates. Data on repeat admissions within a year revealed a total number of 46,610 major breast surgeries between 2001 and 2008, with an overall +3.2% AAPC (95%CI:2.8-3.6).ConclusionsIn Italy, NHDRs might represent a valuable supplemental data source to integrate Cancer Registries in cancer surveillance.

show abstract

Section: Discussionmentioning

confidence: 99%

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records

Piscitelli

Barba²,

Crespi³

et al. 2012

J Exp Clin Cancer Res

View full text Add to dashboard Cite

show abstract

“…The implementation of the National Program of Cancer Registries (NPCR) in 1992 signified a push to expand and augment state cancer registries and was a crucial step in developing a system that permitted up-to-date cancer surveillance. This, in turn, enhanced research efforts to shed light on cancer distribution, population heterogeneity, and environmental etiologies, all required for more efficient resource allocation for education and screening purposes [ 13 – 15 ]. To ensure that these registries obtain accurate and comprehensive data, it is crucial to recognize gaps in data reporting and generate tools targeted at minimizing this gap as much as possible.…”

Section: Discussionmentioning

confidence: 99%

Reporting Melanoma: A Nationwide Surveillance of State Cancer Registries

Raji

Payne

Chen

2015

Journal of Skin Cancer

View full text Add to dashboard Cite

The goal of our study was to determine current melanoma reporting methods available to dermatologists and dermatopathologists and quantify changes in reporting methods from 2012 to 2014. A cross-sectional study design was utilized consisting of website perusal of reporting procedures, followed up by telephone and email inquiry of reporting methods from every state cancer registry. This study was conducted over a six-month period from February to August 2014. A previous similar survey was conducted in 2012 over the same time frame and results were compared. Kansas state cancer registry provided no data. As of August 2014, 96% of 49 state cancer registries had electronic methods available to all designated reporters. Seven (14%) states required an electronic-only method of reporting melanoma cases. Eighty-six percent allowed hard copy pathology report submission. Compared to the 2012 survey, 2 additional states were found to have initiated electronic reporting methods by 2014. In conclusion, a variety of methods exist for reporting diagnosed melanoma cases. Although most state cancer registries were equipped for electronic transmission of cases for mandated reporters, a number of states were ill-equipped for electronic submission from outpatient dermatologists. There was a general trend towards electronic versus nonelectronic reporting from 2012 to 2014.

show abstract

“…Population-based studies ( 7 ) reporting information about HPVV uptake are helpful to identify determinants associated with poor vaccination. Hence, vaccination programs or campaigns geared toward reaching populations with low HPVV uptake can be designed to improve coverage.…”

Section: Introductionmentioning

confidence: 99%

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

2015

View full text Add to dashboard Cite

BackgroundCervical cancer is the fourth most common cancer affecting women worldwide. Since 2006, two human papillomavirus vaccines (HPVV) have been licensed to protect women against the virus that causes cervical cancer. However, worldwide coverage remains unequal. Studies from the USA found strong evidence for differences in HPVV uptake by ethnicity and healthcare coverage. As the profile of ethnic groups and the healthcare system in the USA differ from countries in Europe where HPVV is free in most of the countries, we conducted a systematic review in order to analyze the determinants of HPVV uptake in Europe.MethodsWe performed a systematic Pubmed, Scopus, and Science Direct search to find articles published from HPVV availability in European countries until April 2014. No age restriction was applied. We included all studies assessing factors associated with HPVV uptake. Uptake refers to either initiation and/or completion of the three dose vaccination program.ResultsOut of the 23 eligible studies, 14 were retrospective reviews of data, six were cross-sectional surveys, and three were prospective cohort studies. Higher HPVV uptake was associated with ethnic majority populations, higher socio-economic status, regular cervical screening participation by the mother, and having received previous childhood vaccinations.ConclusionSince the vaccine is offered for free in most of the European countries, the findings suggest that ethno-cultural and educational factors play an important role when it comes to HPVV uptake. Girls who were undervaccinated had also a lower uptake of standard childhood vaccines and mothers who were less likely to attend cervical cancer screening. This may indicate that only few parents have specific concerns with HPVV, and that preventive health care should seek ways to target these vulnerable groups.

show abstract

The potential and limitations of data from population-based state cancer registries

Cited by 104 publications

References 15 publications

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records

The burden of breast cancer in Italy: mastectomies and quadrantectomies performed between 2001 and 2008 based on nationwide hospital discharge records

Reporting Melanoma: A Nationwide Surveillance of State Cancer Registries

Determinants in the Uptake of the Human Papillomavirus Vaccine: A Systematic Review Based on European Studies

Contact Info

Product

Resources

About